← Companies|Fred Hutch Cancer Ctr
Fr

Fred Hutch Cancer Ctr

NPSeattle WAFounded 19753,500 employees
Private CapacadPrivateOncology
Platform: Cancer Center
Market Cap
N/A
All Drugs
8
Clinical Trials
8
Failed / Terminated
2
FDA Approved
0
Drug Pipeline (8 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
FRE-IIT-644FRE-IIT-644Phase 31siRNALAG-3USP1iPTSD
FRE-IIT-285FRE-IIT-285NDA/BLA1MultispecificEGFRIL-13iPsA
FRE-IIT-743FRE-IIT-743NDA/BLA1DegraderKRASG12DPCSK9iGastric Ca
FRE-IIT-474FRE-IIT-474Phase 21VaccineBCL-2MeniniHS
FRE-IIT-954FRE-IIT-954Phase 2/31PeptideFGFRAHRantEndometrial Ca
FRE-IIT-769FRE-IIT-769Phase 2/31Gene TherapyPLK4CFTRmodAML
FRE-IIT-381FRE-IIT-381Phase 21PeptideKRASG12CSOS1iFTD
FRE-IIT-874FRE-IIT-874NDA/BLA1DegraderPARPAuroraAiNMOSD
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (6)
2027-11-11
FRE-IIT-285 Ph3 Readout
PsA
Ph3 Readout
2027-11-24
FRE-IIT-874 Ph3 Readout
NMOSD
Ph3 Readout
2028-12-03
FRE-IIT-954 Ph3 Readout
Endometrial Ca
Ph3 Readout
2028-12-07
FRE-IIT-769 Ph3 Readout
AML
Ph3 Readout
2030-10-20
FRE-IIT-474 Ph2 Data
HS
Ph2 Data
2031-04-22
FRE-IIT-743 Ph3 Readout
Gastric Ca
Ph3 Readout